[CLINICAL CONSIDERATIONS ON THE ACTIVITY AND POSSIBILITY OF USE OF A NEW ORAL HYPOGLYCEMIC BASED ON A COMBINATION OF CHLORPROPAMIDE AND PHENETHYLBIGUANIDE IN VARIOUS TYPES OF DIABETES MELLITUS].
Explore the source record for details and available documents.
Biomedical Research↗